Suppression by Metallothionein of Doxorubicin-induced Cardiomyocyte Apoptosis through Inhibition of p38 Mitogen-activated Protein Kinases
Open Access
- 1 May 2000
- journal article
- Published by Elsevier
- Vol. 275 (18) , 13690-13698
- https://doi.org/10.1074/jbc.275.18.13690
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- Antioxidant activity of metallothionein compared with reduced glutathioneLife Sciences, 1997
- Adriamycin induces apoptosis in rat thymocytesCancer Letters, 1997
- Molecular Cloning and Characterization of a Novel Protein Kinase with a Catalytic Domain Homologous to Mitogen-activated Protein Kinase Kinase KinaseJournal of Biological Chemistry, 1996
- Doxorubicin-induced Apoptosis in Spontaneously Hypertensive Rats: Differential Effects in Heart, Kidney and Intestine, and Inhibition by ICRF-187Journal of Molecular and Cellular Cardiology, 1996
- The interaction of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycinInflammation Research, 1989
- Involvement of cardiac metallothionein in prevention of adriamycin induced lipid peroxidation in the heartToxicology, 1988
- METALLOTHIONEINAnnual Review of Biochemistry, 1986
- Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicalsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977